Shrujna completed a Bachelor of Advanced Science, with Honours in Neuroscience, from the University of New South Wales in 2016. She has a strong background in laboratory science, with expertise in the cellular and molecular processes of the nervous system. Her PhD project focusses on the role of the immune system and neuroinflammation in the pathophysiology of Autism Spectrum Disorders. She is currently involved in collecting and analysing blood samples from children in the oxytocin clinical trial, investigating biomarkers of neuroinflammation and ASD.